MedPath

Butalbital, Aspirin, and Caffeine

Butalbital, Aspirin, and Caffeine Capsules, USP C-IIIRevised: June 2009 1901100609

Approved
Approval ID

166e131d-9c1a-461f-bf33-e45d4ec36ff2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 23, 2013

Manufacturers
FDA

Aidarex Pharmaceuticals LLC

DUNS: 801503249

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

butalbital, aspirin, and caffeine

PRODUCT DETAILS

NDC Product Code33261-922
Application NumberNDA017534
Marketing CategoryC73605
Route of AdministrationORAL
Effective DateDecember 26, 2013
Generic Namebutalbital, aspirin, and caffeine

INGREDIENTS (10)

BUTALBITALActive
Quantity: 50 mg in 1 1
Code: KHS0AZ4JVK
Classification: ACTIB
ASPIRINActive
Quantity: 325 mg in 1 1
Code: R16CO5Y76E
Classification: ACTIB
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
CAFFEINEActive
Quantity: 40 mg in 1 1
Code: 3G6A5W338E
Classification: ACTIB
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
FD&C GREEN NO. 3Inactive
Code: 3P3ONR6O1S
Classification: IACT
GELATINInactive
Code: 2G86QN327L
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Butalbital, Aspirin, and Caffeine - FDA Drug Approval Details